AAAAAA
Results:
1-12
|
Results: 12
Authors:
ROSENKRANZ B
BETTMER J
BUSCHER W
BREER C
CAMMANN K
Citation: B. Rosenkranz et al., THE BEHAVIOR OF DIFFERENT ORGANOMETALLIC COMPOUNDS IN THE PRESENCE OFINORGANIC MERCURY(II) - TRANSALKYLATION OF MERCURY SPECIES AND THEIR ANALYSIS BY THE GC-MIP-PED SYSTEM, Applied organometallic chemistry, 11(9), 1997, pp. 721-725
Authors:
ROSENKRANZ B
BREER CB
BUSCHER W
BETTMER J
CAMMANN K
Citation: B. Rosenkranz et al., THE PLASMA EMISSION DETECTOR - A SUITABLE DETECTOR FOR SPECIATION ANDSUM PARAMETER ANALYSIS, Journal of analytical atomic spectrometry, 12(9), 1997, pp. 993-996
Authors:
ROSENKRANZ B
WINKELMANN BR
PARNHAM MJ
Citation: B. Rosenkranz et al., CLINICAL PHARMACOKINETICS OF MOLSIDOMINE, Clinical pharmacokinetics, 30(5), 1996, pp. 372-384
Authors:
ROSENKRANZ B
Citation: B. Rosenkranz, PHARMACOKINETIC BASIS FOR THE SAFETY OF GLIMEPIRIDE IN RISK GROUPS OFNIDDM PATIENTS, Hormone and Metabolic Research, 28(9), 1996, pp. 434-439
Authors:
ROSENKRANZ B
PROFOZIC V
METELKO Z
MRZLJAK V
LANGE C
MALERCZYK V
Citation: B. Rosenkranz et al., PHARMACOKINETICS AND SAFETY OF GLIMEPIRIDE AT CLINICALLY EFFECTIVE DOSES IN DIABETIC-PATIENTS WITH RENAL IMPAIRMENT, Diabetologia, 39(12), 1996, pp. 1617-1624
Authors:
MEYER BH
SCHOLTZ H
LUUS HG
GROTSCH H
ROSENKRANZ B
FRIESEN HJ
Citation: Bh. Meyer et al., PHARMACOKINETIC AND PHARMACODYNAMIC DOSE LINEARITY OF IV R-HIRUDIN INHEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 20-20
Authors:
FARKER K
NASSR N
HUCK F
ZERLE G
ROSENKRANZ B
SCHMIEDER G
HOFFMANN A
Citation: K. Farker et al., DIPYRONE AND DICLOFENAC DO NOT INFLUENCE CREATININE-CLEARANCE, INULIN-CLEARANCE OR PAH-CLEARANCE IN HEALTHY MALE-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 33(3), 1995, pp. 125-130
Authors:
LEVY M
ZYLBERKATZ E
ROSENKRANZ B
Citation: M. Levy et al., CLINICAL PHARMACOKINETICS OF DIPYRONE AND ITS METABOLITES, Clinical pharmacokinetics, 28(3), 1995, pp. 216-234
Authors:
MEYER BH
MULLER FO
DELAREY N
LUUS HG
ROSENKRANZ B
Citation: Bh. Meyer et al., THE EFFECTS OF BUSERELIN MICROPARTICLES ON OVARIAN-FUNCTION IN HEALTHY WOMEN, South African medical journal, 85(8), 1995, pp. 766-767
Authors:
ROSENKRANZ B
MALERCZYK V
LEHR KH
RINGOIR S
LAMEIRE NH
METELKO Z
PROFOZIC V
Citation: B. Rosenkranz et al., KINETICS AND EFFICACY OF GLIMEPIRIDE IN DIABETIC-PATIENTS WITH KIDNEY-DISEASE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 207-207
Authors:
BACHER P
MARKWARDT F
MESSMORE H
FAREED J
WALENGA J
HOPPENSTEADT D
OFOSU F
FINK E
AMIRAL J
FENTON J
SAWYER R
MARAGANORE J
BREDDIN HK
LEYA F
HUBBARD T
STEMBERGER A
KAISER B
ROSENKRANZ B
KU C
BUTTI A
PIFARRE R
Citation: P. Bacher et al., MEDICAL AND SURGICAL USES OF RECOMBINANT HIRUDIN - AN INTERNATIONAL DISCUSSION FORUM MUNICH, GERMANY, JUNG 26, 1991, Seminars in thrombosis and hemostasis, 19, 1993, pp. 210-216
Authors:
VEYS N
LAMEIRE N
MALERCZYK V
LEHR KH
RINGOIR S
ROSENKRANZ B
Citation: N. Veys et al., SINGLE-DOSE PHARMACOKINETICS OF CEFPIROME IN PATIENTS RECEIVING HEMODIALYSIS AND IN PATIENTS TREATED BY CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Clinical pharmacology and therapeutics, 54(4), 1993, pp. 395-401
Risultati:
1-12
|